![Michael Tolpa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael J.
Tolpa is Treasurer & Director at Sanofi AATD, Inc. since 2024 and Treasurer at Provention Bio, Inc. since 2023.
Formerly, Mr. Tolpa was Treasurer at Blueprint Medicines Corp.
and Treasurer at Translate Bio, Inc.
Aktiva positioner av Michael Tolpa
| Företag | Position | Start |
|---|---|---|
| INHIBRX, INC. | Direktör/Styrelseledamot | 2024-05-30 |
| PROVENTION BIO, INC. | Treasurer | 2023-04-27 |
Tidigare kända positioner av Michael Tolpa
| Företag | Position | Slut |
|---|---|---|
| TRANSLATE BIO, INC. | Treasurer | - |
| BLUEPRINT MEDICINES CORPORATION | Direktör/Styrelseledamot | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
28
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
